Why Brazilian 'Ozempic' may take time and patent expiration probably won’t lower prices
The expiration of the semaglutide patent in Brazil will not lead to immediate price reductions for Ozempic due to regulatory and logistical challenges.
Heir to a pharmaceutical company, queen of the Águia de Ouro drum corps appears with a costume of 50 thousand crystals in rehearsal
Renata Spallicci, the queen of the Águia de Ouro drum corps and executive vice president of Apsen Farmacêutica, dazzled in a crystal-studded costume during a rehearsal at the Sambódromo do Anhembi in São Paulo.